PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17764884-0	2008	Association of GSTP1 expression with resistance to docetaxel and paclitaxel in human breast cancers.	Docetaxel	51-60	glutathione S-transferase pi 1	Homo sapiens	15-20	
35465297-1	2022	Objective: To determine the efficacy and safety of intermittent docetaxel chemotherapy guided by circulating methylated glutathione S-transferase Pi-1 (mGSTP1) in men with metastatic castration-resistant prostate cancer (CRPC).	Docetaxel	64-73	glutathione S-transferase pi 1	Homo sapiens	120-150	
30466891-2	2019	Detection of serum free methylated GSTP1 (mGSTP1) DNA is associated with overall survival (OS) and response to docetaxel in metastatic castration-resistant prostate cancer (mCRPC) in test and internal validation cohorts.	Docetaxel	111-120	glutathione S-transferase pi 1	Homo sapiens	35-40	
17764884-9	2008	CONCLUSION: Our present study has suggested that GSTP1 protein expression, but not GSTP1 methylation status, might be associated with response to docetaxel and paclitaxel.	Docetaxel	146-155	glutathione S-transferase pi 1	Homo sapiens	49-54	
17764884-10	2008	This suggests that GSTP1 immunohistochemical expression might be a potentially clinically useful predictive factor for response to docetaxel and paclitaxel.	Docetaxel	131-140	glutathione S-transferase pi 1	Homo sapiens	19-24	
35501422-12	2022	CONCLUSION: Docetaxel effectiveness was influenced by SNPs in GSTP1, CYP3A, and SLCO1B1 in premenopausal women with non-distant metastatic breast cancer, likely related to altered docetaxel pharmacokinetics.	Docetaxel	12-21	glutathione S-transferase pi 1	Homo sapiens	62-67	
35501422-12	2022	CONCLUSION: Docetaxel effectiveness was influenced by SNPs in GSTP1, CYP3A, and SLCO1B1 in premenopausal women with non-distant metastatic breast cancer, likely related to altered docetaxel pharmacokinetics.	Docetaxel	180-189	glutathione S-transferase pi 1	Homo sapiens	62-67	
19223573-0	2009	Relationship between GSTP1 Ile(105)Val polymorphism and docetaxel-induced peripheral neuropathy: clinical evidence of a role of oxidative stress in taxane toxicity.	Docetaxel	56-65	glutathione S-transferase pi 1	Homo sapiens	21-26	
17764884-1	2008	AIMS: It has been reported that glutathione S-transferase P1 (GSTP1) expression is implicated in resistance to taxanes (docetaxel and paclitaxel) in human breast cancer cells in vitro.	Docetaxel	120-129	glutathione S-transferase pi 1	Homo sapiens	32-60	
17764884-1	2008	AIMS: It has been reported that glutathione S-transferase P1 (GSTP1) expression is implicated in resistance to taxanes (docetaxel and paclitaxel) in human breast cancer cells in vitro.	Docetaxel	120-129	glutathione S-transferase pi 1	Homo sapiens	62-67	
17764884-2	2008	In the study presented here, we examine whether GSTP1 expression is associated with resistance to docetaxel or paclitaxel in human breast cancers.	Docetaxel	98-107	glutathione S-transferase pi 1	Homo sapiens	48-53	
17764884-7	2008	The subset analysis showed that the mean reduction rate was significantly (p=0.005) higher in GSTP1 negative (0.59+/-0.06) than GSTP1 positive (0.11+/-0.13) tumors in the docetaxel group as well as in the paclitaxel group (p=0.006; GSTP1 negative tumors: 0.84+/-0.05; GSTP1 positive tumors: 0.56+/-0.08).	Docetaxel	171-180	glutathione S-transferase pi 1	Homo sapiens	94-99	
17764884-7	2008	The subset analysis showed that the mean reduction rate was significantly (p=0.005) higher in GSTP1 negative (0.59+/-0.06) than GSTP1 positive (0.11+/-0.13) tumors in the docetaxel group as well as in the paclitaxel group (p=0.006; GSTP1 negative tumors: 0.84+/-0.05; GSTP1 positive tumors: 0.56+/-0.08).	Docetaxel	171-180	glutathione S-transferase pi 1	Homo sapiens	128-133	
17764884-7	2008	The subset analysis showed that the mean reduction rate was significantly (p=0.005) higher in GSTP1 negative (0.59+/-0.06) than GSTP1 positive (0.11+/-0.13) tumors in the docetaxel group as well as in the paclitaxel group (p=0.006; GSTP1 negative tumors: 0.84+/-0.05; GSTP1 positive tumors: 0.56+/-0.08).	Docetaxel	171-180	glutathione S-transferase pi 1	Homo sapiens	128-133	
17764884-7	2008	The subset analysis showed that the mean reduction rate was significantly (p=0.005) higher in GSTP1 negative (0.59+/-0.06) than GSTP1 positive (0.11+/-0.13) tumors in the docetaxel group as well as in the paclitaxel group (p=0.006; GSTP1 negative tumors: 0.84+/-0.05; GSTP1 positive tumors: 0.56+/-0.08).	Docetaxel	171-180	glutathione S-transferase pi 1	Homo sapiens	128-133